For example, a report published by Pilarski and colleagues [43] detected the development of an adenocarcinoma of unknown primary—which was defined as from CCA—in a patient with a BAP1 germline truncating mutation (c.1182C>G, p.Tyr394*). This evidence concerns the gene BAP1 and adenocarcinoma.